RARRES2 and Insulin resistance: Elevated chemerin levels show the interlinking of metabolic syndrome and obesity by producing pathophysiological complications such as increased fat, glucose, lipid metabolism, inflammation, and elevated blood pressure that lead to hyperlipidemia and insulin resistance.